Early ileocolonoscopy with biopsy for the evaluation of persistent post-transplantation diarrhea

World Journal of Gastroenterology

Volumn 16, Issue 30, 2010, Pages 3834-3840

  Bamias, Giorgos ^a   Boletis, John ^b   Argyropoulos, Theodoros ^a   Skalioti, Chrysanthi ^b   Siakavellas, Spyros I ^a   Delladetsima, Ioanna ^c   Zouboulis Vafiadis, Irene ^a   Daikos, George L ^a   Ladas, Spiros D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Endoscopy; Enteric infections; Histology; Mycophenolate mofetilcolitis; Post transplantation diarrhea

Indexed keywords

CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; INFECTIOUS DIARRHEA; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION;

EID: 77955752048     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i30.3834     Document Type: Article

References (26)

1. Gil-Vernet S, Amado A, Ortega F, Alarcón A, Bernal G, Capdevila L, Crespo JF, Cruzado JM, De Bonis E, Esforzado N, Fernandez AM, Franco A, Hortal L, Jiménez C. Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc 2007; 39: 2190-2193
2. Altiparmak MR, Trablus S, Pamuk ON, Apaydin S, Sariyar M, Oztürk R, Ataman R, Serdengeçti K, Erek E. Diarrhoea following renal transplantation. Clin Transplant 2002; 16: 212-216
3. Gaston RS, Kaplan B, Shah T, Cibrik D, Shaw LM, Angelis M, Mulgaonkar S, Meier-Kriesche HU, Patel D, Bloom RD. Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant 2009; 9: 1607-1619
4. Ekberg H, Kyllönen L, Madsen S, Grave G, Solbu D, Holdaas H. Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients. Transplantation 2007; 83: 282-289
5. Bunnapradist S, Neri L, Wong W, Lentine KL, Burroughs TE, Pinsky BW, Takemoto SK, Schnitzler MA. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008; 51: 478-486
6. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005; 18: 643-650
7. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002; 13: 277-287
8. Subramanian AK, Sears CL. Infectious diarrhea in transplant recipients: current challenges and future directions. Transpl Infect Dis 2007; 9: 263-264
9. Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand MR. Infectious complications after kidney transplantation: a single-center experience. Transpl Infect Dis 2007; 9: 302-309
10. Miller J, Mendez R, Pirsch JD, Jensik SC. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Transplantation 2000; 69: 875-880
11. Arns W. Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc 2007; 39: 88-93
12. Dalle IJ, Maes BD, Geboes KP, Lemahieu W, Geboes K. Crohn's-like changes in the colon due to mycophenolate? Colorectal Dis 2005; 7: 27-34
13. Papadimitriou JC, Cangro CB, Lustberg A, Khaled A, Nogueira J, Wiland A, Ramos E, Klassen DK, Drachenberg CB. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol 2003; 11: 295-302
14. Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, Moreau J, Rostaing L. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int 2004; 17: 463-467
15. Bunnapradist S, Lentine KL, Burroughs TE, Pinsky BW, Hardinger KL, Brennan DC, Schnitzler MA. Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 2006; 82: 102-107
16. Maes B, Hadaya K, de Moor B, Cambier P, Peeters P, de Meester J, Donck J, Sennesael J, Squifflet JP. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant 2006; 6: 1466-1472
17. Pelletier RP, Akin B, Henry ML, Bumgardner GL, Elkhammas EA, Rajab A, Ferguson RM. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 2003; 17: 200-205
18. Knoll GA, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003; 14: 2381-2386
19. Pascual J, Ocaña J, Marcén R, Fernández A, Galeano C, Alarcón MC, Burgos FJ, Villafruela JJ, Ortuño J. Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients. Transplant Proc 2006; 38: 2398-2399
20. Korkmaz M, Kunefeci G, Selcuk H, Unal H, Gur G, Yilmaz U, Arslan H, Demirhan B, Boyacioglu S, Haberal M. The role of early colonoscopy in CMV colitis of transplant recipients. Transplant Proc 2005; 37: 3059-3060
21. Korkmaz M, Gür G, Yilmaz U, Karakayali H, Boyacioǧlu S, Haberal M. Colonoscopy is a useful diagnostic tool for transplant recipients with lower abdominal symptoms. Transplant Proc 2004; 36: 190-192
22. Baysal C, Gür G, Gürsoy M, Ustündaǧ Y, Demirhan B, Boyacioǧlu S, Bilgin N. Colonoscopy findings in renal transplant patients with abdominal symptoms. Transplant Proc 1998; 30: 754-755
23. Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant 2001; 15 Suppl 4: 11-22
24. Hardinger KL, Brennan DC, Lowell J, Schnitzler MA. Longterm outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 2004; 17: 609-616
25. Davies NM, Grinyó J, Heading R, Maes B, Meier-Kriesche HU, Oellerich M. Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant 2007; 22: 2440-2448
26. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751